MLLT3 and acute myeloid leukemia: In vivo, 12,000 iMLL-AF9 GMPs induced lethal AML in all animals tested (Fig. 1c, Supplementary Fig. 2a–d), confirming that iMLL-AF9 induction could transform GMPs de novo.